Cytta files to adopt OTC - Pink Open Market Alternative

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
48
Cytta files to adopt OTC - Pink Open Market Alternative Reporting Standard

Danville, CA, June 20, 2017 (GLOBE NEWSWIRE) -- Cytta Corp. (OTCPINK:CYCA), a leading provider of mobile monitoring, compression and broadband solutions, today announces that it had voluntarily filed a Form 15 with the United States Securities and Exchange Commission (the "Commission" or "SEC") to allow the Company to elevate its status on the OTC Markets Group - Pink Open Market to the “Current Information” disclosure category.

"In today’s challenging microcap environment, there is a high cost to being an SEC reporting issuer without any appreciable benefit. Embracing our new non-reporting status, will allow our management team to focus on our ongoing growth and building the long-term value of our Company. We are not an isolated case, as 8174 companies are now traded on the OTC Pink Open Market Alternative Reporting Standard , with only 944 remaining as SEC reporting issuers on the OTCQB. This seismic shift in the marketplace is a fallout of the market crash of 2008 and the expense and difficulties of maintaining SEC reporting obligations, without corresponding microcap market opportunity and/or benefit. " stated CEO Gary Campbell.

The Form 15 also provided notice of the statutory deregistration its common stock and elimination of its SEC reporting obligations under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). This allows Cytta to file unaudited management prepared Financial Statements, instead of the far more onerous and expensive Sarbanes-Oxley Audited Financial Statements.  Cytta will be disclosing its management prepared Annual and Quarterly Financial Statements through the OTC Markets Alternative Reporting Standard (ARS) and News Service. Cytta currently trades on the Pink Open Market with seven broker dealers currently acting as market makers.

With the filing of Form 15 with the SEC, the Company gives notice that it is no longer required to file certain reports under the Exchange Act, including quarterly reports on Form 10-Q, annual reports on Form 10-K, and current reports on Form 8-K. Despite the termination of its SEC reporting obligations, the Company may continue to voluntarily file Form 8-K’s with the Commission to disclose material events and provide better information dissemination.

Cytta’s Board of Directors voted unanimously to file Form 15 after deliberation and consideration of the advantages and disadvantages of being an SEC reporting company. The Company's Board of Directors considered many elements in reaching their decision, including; the substantial costs, both direct and indirect, associated with the preparation and filing of periodic reports with the SEC, the current level of analysts coverage, the minimal liquidity for the Company's common stock, the additional outside legal and auditing resources required, the amount of time management spends on reporting documents, the uncertainty across the broader public market for microcap reporting stocks, as well as the advantages and disadvantages of the trading of the Company's common stock on the OTCQB versus the OTCPINK marketplace.

About Cytta Corp.( www.Cytta.com )

Cytta Corp.’s business model entails developing and/or securing disruptive technologies, building industry specific business models utilizing the technology and licensing or partnering with enterprise level organizations able to implement the technology into their specific industry segments. Specifically, Cytta Corp. develops and integrates technologies in the smartphone, compression and mobile broadband space.  Cytta has developed Proprietary Android Control Interface (PACI) which it has implemented as an IoT remote monitoring connectivity system through its VeriSmartPhone™ platform. This platform is a highly scalable and secure IoT two-way real time monitoring android control interface initially deployed in a Doctor Direct/EvrCare™ healthcare solution which is being licensed. The Cytta VeriSmartPhone™ technology consists of an ‘intelligent’ android smartphone reprogrammed at the operating system level as an IoT control interface. The Cytta Connect technology automatically connects all remote monitoring devices to the Cloud/IoT platform creating real time communication for all IoT market segments. To their PACI technology they have added the CIFF Compression System which provides compression features and capabilities that are unattainable by any other image/video compression technology. CIFF is paradigm shifting technology that, in many important areas, exceeds current day compression and decompression technologies. The Cytta mobile broadband technology is currently being assessed and evaluated.

Safe Harbor Statement/ Forward-Looking Statements

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, the impact of any product liability or other adverse litigation, working capital and availability of capital, commercialization and technological difficulties, the impact of actions and events involving key customers, vendors, lenders, competitors, and other risks. Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release, the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will", and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward looking statements, whether as a result of future events, new information, or otherwise.

Cytta Corp. Gary Campbell, CEO Direct (702) 900 7022 Email: Gary@Cytta.com Website: www.Cytta.com Jerry Smith, Co-CEO Direct (425) 922-7062 Email: Jl@JlSmith.us Doctor Direct Inc. Natalia Sokolova, President Direct (917) 574 2312 Email: natalia@doctordirectinc.com Website: www.DoctorDirectInc.com Investor Relations Contact: Complete Advisory Partners Office: (586) 228-2290 Cell: (586) 801-9002 Email: CapInc@comcast.net

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DAN, GPRO, PSNL Deals Under Investor Scrutiny

Updated Category News Views 40

Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...

Continue Reading
Raytron Dominates Global Thermal Imaging Market in 2026

Updated Category News Views 106

Raytron's Market Supremacy: By the Numbers If you're looking at the thermal imaging sector and wondering what's what, take a clue from Raytron. This outfit isn't just playing the game—it's running the show with a staggering 30% of the global market in 2025. That's right, they hold the medal for leading global shipments in thermal imaging, and unlike many industries...

Continue Reading
Asphalt Additives Market Set for $7.07B Boom by 2031

Updated Category News Views 65

Asphalt Additives: A Lucrative Growth Path Let me tell you, the asphalt additives market isn't just sticking to the roads; it's rolling out real potential. Heading for a $7.07B finish line by 2031 with a steady pace of 7.3% CAGR, it's a road worth staking your claims on. The underlying story? It's more than just laying tar. Pavement to Profit: Key Drivers The asphalt...

Continue Reading
Pearl Meyer Leaders Grab NACD's Coveted Governance Honor

Updated Category News Views 26

NACD Recognition for Governance Grit Some folks just know how to steer a ship, and that's exactly what Pearl Meyer's Matt Turner and Jannice Koors have been doing. This year, they made it onto the NACD's 2026 Directorship 100 list, swinging as heavy hitters in the Governance Professionals category. It's not just another day at the office when you're honored by the...

Continue Reading
Epson Unveils Early Black Friday Tech Deals

Updated Category News Views 69

Diving Headfirst into Holiday Tech Splurging The holiday hustle is upon us, folks, and Epson's stepping up with early Black Friday deals that'll have tech heads scrambling. They’re cutting prices up to $250 on their swanky home lineup—projectors, printers, scanners, you name it. This ain't just about making someone else smile, though; it's about the sweet spot where...

Continue Reading
Doximity's Legal Woes: Class Action Deadline Looms

Updated Category News Views 15

The Truth Behind Doximity's Promises The brass tacks of investing often boil down to trust—a commodity that's now in short supply over at Doximity, Inc. (NYSE: DOCS). Investors have been left hanging after promises of lucrative engagement signals turned out to be a mere pipe dream. Levi & Korsinsky, LLP sounds the alarm on what's shaping up to be a high-stakes class...

Continue Reading
Insulin Delivery Devices: A Billion-Dollar Surge

Updated Category News Views 20

When's the last time you saw a medical device market promising a $10 billion leap in under five years? Yeah, the insulin delivery devices market's got that kind of upside, projected to skyrocket from $16.92 billion in 2026 to a whopping $26.37 billion by 2031. That's a 9.3% annual growth rate. The numbers and the stakes are both staggering. Regional and Segment Leaders...

Continue Reading
Peanuts and Diabetes: A Surprising Health Link

Updated Category News Views 68

A Nutty Approach to Diabetes Prevention Who would've thought peanuts could pack such a punch against diabetes? Amid the usual suspects of healthy foods, it's these humble legumes that are making headlines. The Peanut Institute, backed by fresh research, is shining a spotlight on their potential role in preventing type 2 diabetes, a disease that's affecting roughly 40...

Continue Reading
Terra-Gen's $950M Lockhart Facility Powers California

Updated Category News Views 128

A New Giant in California's Solar Landscape Out in California's desert, Terra-Gen has flipped the switch on something pretty colossal: the $950 million Lockhart Solar and Storage Project. Picture this—a solar beast boasting 538.7 MW of capacity, primed to light up around 350,000 homes and businesses. That's not just flipping a light switch; that's sparking a fire that...

Continue Reading
Defense Contractors Push Forward Amid Indictments

Updated Category News Views 18

The Big Names Hold Steady Defense contractors are showing off their shiny earnings just as some disturbing headlines shake things up. It's like they're putting their best foot forward to steady the ship while the waters get choppy with terrorism charges and all sorts of geopolitical noise. Follow the smart money to see where the true bets are being placed—it all unfolds...

Continue Reading

Top 5 Most Recently Viewed Articles

Twilio's Q4 Results Spark Diverse Analyst Reactions

Updated Category News Views 232

Twilio Inc Fourth Quarter Overview Twilio Inc reported notable financial results for the fourth quarter, capturing the attention of several analysts within the market. The company’s performance has sparked diverse reactions, particularly regarding its future guidance and the evolving role of artificial intelligence within its operations. Market Response to Q4 Earnings...

Continue Reading
FHLBank Indianapolis Dividends for Second Quarter of 2025

Updated Category News Views 180

FHLBank Indianapolis Declares Second Quarter Dividends FHLBank Indianapolis recently announced its second quarter dividends for 2025, detailing robust financial strategies and growth, as reflected in the declared dividends on Class B-2 activity-based capital stock and Class B-1 non-activity-based stock. These dividends have been set at annualized rates of 9.50% and 4.50%,...

Continue Reading
Neurogen Biomarking Partners with Quanterix for Alzheimer's Testing

Updated Category News Views 255

Revolutionizing Alzheimer's Detection with Neurogen Biomarking Neurogen Biomarking is making significant strides in the healthcare landscape by introducing a pioneering blood test aimed at the early detection of Alzheimer's disease and Mild Cognitive Impairment (MCI). This innovative approach leverages advanced biomarker technology developed by Quanterix Corporation,...

Continue Reading
Kepler Robotics Launches Innovative Humanoid Robot for Industries

Updated Category News Views 296

Revolutionizing Industries with the K2 Bumblebee Shanghai Kepler Robotics Co., Ltd has excitedly announced the commencement of mass production of its K2 "Bumblebee" model, confirming that the world's first commercially available hybrid-architecture humanoid robot is now shipping to eager customers. Milestone in Humanoid Robotics This significant development not only marks...

Continue Reading
Syntara Limited Reveals Groundbreaking Data in Myelofibrosis Trials

Updated Category News Views 259

Positive Interim Data from Syntara's Clinical Trials Syntara Limited, known for its innovative approach in drug development, has unveiled promising interim data concerning its ongoing Phase 2 study of SNT-5505. This clinical trial focuses on myelofibrosis, a complex bone marrow disorder that often leads to severe health complications. Details of the Clinical Trial The...

Continue Reading